Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine for blunt chest wall trauma
NCT02749968Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Mar 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal bupivacaine in blunt chest wall trauma, sponsored by University of Cincinnati. Started Mar 2018; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
blunt chest wall trauma
Beyond the preview
Go deeper on NCT02749968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749968.